Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/30/2003US6669903 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus
12/30/2003US6669883 Method and device for producing different solid dosage forms
12/30/2003US6669879 Method for producing solid dosing forms
12/30/2003US6669683 To controlled time and rate release multi-welled delivery devices; drug delivery
12/30/2003US6669682 Veterinary delivery device and method
12/30/2003US6669669 Laminated patient infusion device
12/30/2003US6669122 Method and apparatus for shaping particles by ultrasonic cavitation
12/30/2003CA2346001C Controlled release nanoparticulate compositions
12/30/2003CA2280940C Use of plant extract for inhibition of haemophilus influenzae
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2221356C Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
12/30/2003CA2182786C Process for the production of particles or powders
12/30/2003CA2175971C Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
12/30/2003CA2159908C Manufacturing matrices
12/30/2003CA2158331C Injection vessel and solution-enclosed injection vessel in use thereof
12/30/2003CA2148617C System for dispensing pharmaceutically active compounds
12/30/2003CA2146723C Percutaneous absorption preparation
12/30/2003CA2096537C Method of administering dipalmitoylphosphatidylcholine dispersions
12/30/2003CA2093806C Method of treating or preventing type 1 diabetes by oral administration of insulin
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/29/2003WO2004002469A1 Isoflavone concentrate and method for production thereof
12/29/2003CA2448513A1 Isoflavone concentrates, as well as methods for their production
12/26/2003CA2391691A1 Modified release pharmaceutical composition containing bupropion hci as active substance
12/25/2003WO2003105888A1 Acidic insulin preparations with improved stability
12/25/2003WO2003105809A1 Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
12/25/2003WO2003105611A2 Beverages containing plant sterols
12/25/2003US20030236574 Composition and device for in vivo cartilagerepair
12/25/2003US20030236514 Implantable or insertable medical devices for controlled delivery of a therapeutic agent
12/25/2003US20030236513 Implantable or insertable medical devices for controlled delivery of a therapeutic agent
12/25/2003US20030236339 Invert sugar bubbles
12/25/2003US20030236320 Polyhydroxyalkanoate compositions having controlled degradation rates
12/25/2003US20030236313 Methods for making foamed elastomer gels
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236301 Liposomal delivery of vitamin E based compounds
12/25/2003US20030236300 Releasing confined proteins; administering synergistic mixture of curcumin and enzyme inhibitor
12/25/2003US20030236298 Antiinflammatory agents; antihistamines; skin disorders
12/25/2003US20030236285 Stabilized pharmaceutical compositions containing benzimidazole compounds
12/25/2003US20030236239 In situ therapy for vision defects; photorefractive therapy
12/25/2003US20030236238 Respiratory system disorders; asthma; stable powder form of formoterol; storage stability
12/25/2003US20030236236 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
12/25/2003US20030236217 Administering ADP-ribose
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236207 Particulate complex for administering nucleic acid into a cell
12/25/2003US20030236203 Comprises praziquantel and/or pyrantel in solvent with thickener for improved bioavailability
12/25/2003US20030236196 Polyoxyethylene glycol-modified tumor necrosis factor for higher concentrations, decreased viscosity, and improved stability; for treatment of inflammation
12/25/2003US20030236192 Method of modifying the release profile of sustained release compositions
12/25/2003US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine
12/25/2003US20030235662 Color changing balls and toys
12/25/2003US20030235627 Applying basic drugs to skins for prophylaxis of human papillomavirus infections; skin disoders
12/25/2003US20030235625 Gels comprising mixtures of bismuth subnitrate and aluminium stearate, used as barriers for sealing nipples of cattle; prevention of mastitis
12/25/2003US20030235619 Polymer-lipid delivery vehicles
12/25/2003US20030235618 Mixtures of acetaminophen, neutralized carbopol and polyethylene glycol having high viscocity; sweetening
12/25/2003US20030235617 Pharmaceutical dosage form for mucosal delivery
12/25/2003US20030235616 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery
12/25/2003US20030235615 Antibiotic composition with inhibitor
12/25/2003US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions
12/25/2003US20030235613 Popping oral administration form
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/25/2003US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins
12/25/2003US20030235610 Liposomes containing biologically active compounds
12/25/2003US20030235608 Inserts for magazine advertisements
12/25/2003US20030235607 Compositions and methods for inhibiting fungal growth and transference
12/25/2003US20030235605 Antimicrobial body covering articles
12/25/2003US20030235603 Comprises implantable/insertable implants (catheter, stents)
12/25/2003US20030235598 Cosmetic or pharmaceutical preparations comprising an oxalkylated polyglycerol ester
12/25/2003US20030235596 Process for preparing a finely self-emulsifiable pharmaceutical composition
12/25/2003US20030235595 Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235589 Comprises chondroprotective agents, an agent which promotes cartilage anabolic activity, and an agent that inhibits cartilage catabolism; for sustained release; for treatment of neurodegenerative disorders
12/25/2003US20030235571 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
12/25/2003US20030235556 Combination IL-2/anti-HER2 antibody therapy for cancers characterized by overexpression of the HER2 receptor protein
12/25/2003US20030235547 An oil phase, an aqueous phase, a surfactant of water-in-oil type, a surfactant of oil-in-water type and a branched or crosslinked polyelectrolyte
12/25/2003US20030235541 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/25/2003US20030235538 Actuating an inhaler containing powder of tiotropium in admixture with an excipient with an average particle size of 10-500 mu m and having a flow resistance of .01-.1 square root over kPa min/L
12/25/2003US20030235537 Pulmonary delivery in treating disorders of the central nervous system
12/25/2003US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines
12/25/2003US20030235453 Jelly pens
12/25/2003US20030234466 Method of moulding a pharmaceutical composition in a packaging material
12/25/2003US20030234462 Method for making gel including salt reduction step
12/25/2003US20030234198 Method and device for treatment of respiratory tract disorders
12/24/2003WO2003106644A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
12/24/2003WO2003106629A2 Treating vitamin d responsive diseases
12/24/2003WO2003106592A2 Ether alcohols used as solvents and emulsifiers and dispersions containing said ether alcohols
12/24/2003WO2003106536A2 Heat-sensitive polymers and heat reversible gels derived therefrom
12/24/2003WO2003106382A2 Reversed liquid crystalline phases with non-paraffin hydrophobes
12/24/2003WO2003106168A1 Coated particles, methods of making and using
12/24/2003WO2003105907A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
12/24/2003WO2003105905A1 Controlled release composition comprising felodipine and method of preparation thereof
12/24/2003WO2003105903A1 Antifungal medicinal composition
12/24/2003WO2003105894A1 Stabilized liquid anti-rsv antibody formulations
12/24/2003WO2003105890A2 Vaccine composition
12/24/2003WO2003105882A1 Composition comprising viscous fibers and viscosity-lowering proteins
12/24/2003WO2003105859A1 Powdery respiratory tonic composition
12/24/2003WO2003105856A1 Combination of azelastine and steroids
12/24/2003WO2003105848A1 Controlled-release drug composition
12/24/2003WO2003105847A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105841A1 Antifungal medicinal compositions
12/24/2003WO2003105833A1 Formulation of nefopam and its use in the treatment of pain
12/24/2003WO2003105832A1 Use of nefopam for the treatment of nausea or emesis
1 ... 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 ... 2991